Evaluation of anterior capsular contraction syndrome after cataract surgery with commonly used intraocular lenses
Received 25 April 2018
Accepted for publication 12 June 2018
Published 8 August 2018 Volume 2018:12 Pages 1399—1403
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Justinn Cochran
Peer reviewer comments 3
Editor who approved publication: Dr Scott Fraser
Matthew Hartman,1 Michael Rauser,2 Matthew Brucks,2 KV Chalam2
1Department of Ophthalmology, Loma Linda University School of Medicine, Loma Linda, CA, USA; 2Department of Ophthalmology, Loma Linda University Eye Institute, Loma Linda, CA, USA
Purpose: The purpose of this study was to compare the incidence of anterior capsular contraction syndrome (ACCS) in cataract patients after implantation with one of two most commonly used hydrophobic acrylic lenses.
Setting: This study included patients from Loma Linda University, Loma Linda, CA, USA.
Design: This study is a retrospective chart review.
Methods: In this study, 1,047 eyes of 811 patients with and without known ACCS risk factors who underwent successful phacoemulsification and intraocular lens (IOL) implantation were included. Eyes that sustained intraoperative capsular tears and patients with a postoperative follow-up of <1 month were excluded. Each patient underwent surgery by the same surgeon receiving either the SN60WF IOL or the ZCB00 IOL. The duration of postoperative follow-up along with the presence of ACCS and the dimensions of the anterior capsule opening in these cases were recorded. The incidence of ACCS between the two lenses was compared.
Results: ACCS was significantly (P=0.045) less frequent in those patients who received the ZCB00 lens compared to those who received the SN60WF lens, despite a significantly greater (P<0.0001) number of patients with ACCS risk factors in the ZCB00 cohort.
Conclusion: In a direct comparison of the ZCB00 and SN60WF IOLs, a lower incidence of ACCS was found with ZCB00 IOL.
Keywords: acrylic resins, biocompatible materials, capsule opacification, intraocular lens implantation, capsular phimosis, treatment outcome
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]